<%@LANGUAGE="VBSCRIPT" CODEPAGE="1252"%> Sun Pharma Advanced Research Company Ltd. - Annual Report 07-08
HOME   |   BOARD OF DIRECTORS   |   NCE PROJECTS   |   NDDS   |   DIRECTORS' REPORT   |   FINANCIAL SECTION   |   CONTACT   |   CONTENT
     
  Financial Result  
  Dividend  
  Listing of Shares  
  Directors  
  Management
Discussion & Analysis
 
  Corporate
Governance Report
 
  Human Resources <% end if %>  
  Public Deposits  
 
Information on conservation of energy, technology absorption, foreign exchange earning and outgo
 
  Internal Control Systems
and their Adequacy
 
  Directors'
Responsiblity Statement
 
  Auditors  
  Acknowledgements  
 
1  |  2 3
INFORMATION ON CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNING AND OUTGO.
The additional information relating to energy conservation, technology absorption, foreign exchange earning and outgo, pursuant to Section 217(1)(e) of the Companies Act 1956 read with the Companies (Disclosure of Particulars in the Report of the Board of Directors) Rules, 1988, is given in Annexure and forms part of this Report.
INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY
Your Company has adequate internal controls for its business processes across departments to ensure efficient operations, compliance with internal policies, applicable laws and regulations, protection of resources and assets, and accurate reporting of financial transactions. The Company also has an internal audit system which is conducted by an independent firm of Chartered Accountants so as to cover various operations on continuous basis. Summarized Internal Audit Observations/Reports are reviewed by the Audit Committee on a regular basis. The finance and accounts functions of the Company are well staffed with qualified and experienced members.
DIRECTORS' RESPONSIBILITY STATEMENT
Pursuant to the requirement under Section 217(2AA) of the Companies Act, 1956, with respect to Directors' Responsibility Statement, it is hereby confirmed:
that in the preparation of the annual accounts for the financial year ended 31st March, 2008, the applicable accounting standards have been followed along with proper explanation relating to material departures;
that the Directors have selected appropriate accounting policies and applied them consistently and made judgements and estimates that were reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and on the loss of the Company for the year under review;
that the Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 1956 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities; and,
that the Directors have prepared the annual accounts for the financial year ended 31st March, 2008 on a ‘going concern' basis.
AUDITORS
Your Company's auditors, M/s. Deloitte Haskins & Sells, Chartered Accountants, Mumbai, retire at the conclusion of the forthcoming Annual General Meeting. Your Company has received a letter from them to the effect that their re-appointment, if made, will be in accordance with the provisions of Section 224(1-B) of the Companies Act, 1956.
ACKNOWLEDGEMENTS
Your Directors wish to thank all stakeholders and business partners-your Company's bankers, medical profession and business associates for their continued support and valuable co-operation. The Directors also wish to express their gratitude to investors for the faith that they continue to repose in the Company.
For and on behalf of the Board of Directors
Dr. T. Rajamannar Sudhir V. Valia
Whole-time Director Director
   
Mumbai  
14th May, 2008